Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
Dr. Namandjé N. Bumpus Principal Deputy Commissioner - FDA | Official Website
This is a 166.7% increase over the number of companies inspected in the previous year, when three companies were inspected through three inspections.
The companies inspected were involved in either the Food/Cosmetics, Biologics, Devices, or Tobacco sectors.
There were six companies in line with FDA regulations who don’t need to adjust their management operations or regulatory/administrative actions. Two should take voluntary action to correct the organization's management operations.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
The FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.
Company Name | Area of Business | Inspection Date | Result |
---|---|---|---|
Alamance Regional Medical Center Blood Bank | Biologics | 08/16/2023 | No Action Indicated (NAI) |
Becton Dickinson and Company | Devices | 09/15/2023 | No Action Indicated (NAI) |
Laboratory Corporation of America ViroMed Laboratories | Biologics | 10/11/2023 | No Action Indicated (NAI) |
Liggett Group, LLC | Tobacco | 09/07/2023 | No Action Indicated (NAI) |
Rolls Enterprises, Inc. | Food/Cosmetics | 01/20/2023 | Voluntary Action Indicated (VAI) |
Root Chews, LLC | Food/Cosmetics | 05/04/2023 | No Action Indicated (NAI) |
Santa Clara, Inc. | Tobacco | 01/11/2023 | No Action Indicated (NAI) |
Tex-Care Medical | Devices | 12/15/2023 | Voluntary Action Indicated (VAI) |